Immune Design Corp. Operating Expenses
Immune Design Corp. reported Operating Expenses of $59.25 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-03-13
- Immune Design Corp. operating expenses for the quarter ending 2018-12-31 was $14.69M, a 14.22% increase year-over-year.
- Immune Design Corp. operating expenses for the quarter ending 2018-09-30 was $15.10M, a 6.57% increase year-over-year.
- Immune Design Corp. operating expenses for the quarter ending 2018-06-30 was $15.15M, a 2.55% increase year-over-year.
- Immune Design Corp. operating expenses for the quarter ending 2018-03-31 was $14.31M, a 21.40% decline year-over-year.
- Immune Design Corp. operating expenses for fiscal 2018 was $59.25M, a 1.27% decline from fiscal 2017.
- Immune Design Corp. operating expenses for fiscal 2017 was $60.01M, a 11.07% decline from fiscal 2016.
- Immune Design Corp. operating expenses for fiscal 2016 was $67.47M, a 37.72% increase from fiscal 2015.
- Immune Design Corp. operating expenses for fiscal 2015 was $48.99M, a 34.93% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2018-12-31 | $14.69M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $29.79M derived: sum of 2 quarters · filed 2019-03-13 | $44.93M derived: sum of 3 quarters · filed 2019-03-13 | $59.25M 10-K · filed 2019-03-13 |
| 2018-09-30 | $15.10M 10-Q · filed 2018-11-06 | $30.25M derived: sum of 2 quarters · filed 2018-11-06 | $44.56M 10-Q · filed 2018-11-06 | $57.42M derived: sum of 4 quarters · filed 2019-03-13 |
| 2018-06-30 | $15.15M 10-Q · filed 2018-08-01 | $29.46M 10-Q · filed 2018-08-01 | $42.32M derived: sum of 3 quarters · filed 2019-03-13 | $56.49M derived: sum of 4 quarters · filed 2019-03-13 |
| 2018-03-31 | $14.31M 10-Q · filed 2018-05-03 | $27.17M derived: sum of 2 quarters · filed 2019-03-13 | $41.34M derived: sum of 3 quarters · filed 2019-03-13 | $56.11M derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-12-31 | $12.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $27.03M derived: sum of 2 quarters · filed 2019-03-13 | $41.80M derived: sum of 3 quarters · filed 2019-03-13 | $60.01M 10-K · filed 2019-03-13 |
| 2017-09-30 | $14.17M 10-Q · filed 2018-11-06 | $28.94M derived: sum of 2 quarters · filed 2018-11-06 | $47.15M 10-Q · filed 2018-11-06 | $63.73M derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-06-30 | $14.77M 10-Q · filed 2018-08-01 | $32.98M 10-Q · filed 2018-08-01 | $49.56M derived: sum of 3 quarters · filed 2019-03-13 | $70.36M derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-03-31 | $18.21M 10-Q · filed 2018-05-03 | $34.79M derived: sum of 2 quarters · filed 2019-03-13 | $55.59M derived: sum of 3 quarters · filed 2019-03-13 | $71.18M derived: sum of 4 quarters · filed 2019-03-13 |
| 2016-12-31 | $16.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $37.38M derived: sum of 2 quarters · filed 2019-03-13 | $52.97M derived: sum of 3 quarters · filed 2019-03-13 | $67.47M 10-K · filed 2019-03-13 |
| 2016-09-30 | $20.80M 10-Q · filed 2017-11-01 | $36.39M derived: sum of 2 quarters · filed 2017-11-01 | $50.89M 10-Q · filed 2017-11-01 | $64.17M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $15.59M 10-Q · filed 2017-08-02 | $30.09M 10-Q · filed 2017-08-02 | $43.37M derived: sum of 3 quarters · filed 2018-03-14 | $55.44M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $14.51M 10-Q · filed 2017-05-04 | $27.79M derived: sum of 2 quarters · filed 2018-03-14 | $39.85M derived: sum of 3 quarters · filed 2018-03-14 | $52.16M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $13.28M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $25.35M derived: sum of 2 quarters · filed 2018-03-14 | $37.65M derived: sum of 3 quarters · filed 2018-03-14 | $48.99M 10-K · filed 2018-03-14 |
| 2015-09-30 | $12.07M 10-Q · filed 2016-11-09 | $24.37M derived: sum of 2 quarters · filed 2016-11-09 | $35.72M 10-Q · filed 2016-11-09 | $50.64M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-06-30 | $12.30M 10-Q · filed 2016-08-09 | $23.65M 10-Q · filed 2016-08-09 | $38.57M derived: sum of 3 quarters · filed 2017-03-07 | $48.67M derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-03-31 | $11.34M 10-Q · filed 2016-05-10 | $26.27M derived: sum of 2 quarters · filed 2017-03-07 | $36.37M derived: sum of 3 quarters · filed 2017-03-07 | $42.12M derived: sum of 4 quarters · filed 2017-03-07 |
| 2014-12-31 | $14.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $25.02M derived: sum of 2 quarters · filed 2017-03-07 | $30.77M derived: sum of 3 quarters · filed 2017-03-07 | $36.31M 10-K · filed 2017-03-07 |
| 2014-09-30 | $10.10M 10-Q · filed 2015-11-12 | $15.85M derived: sum of 2 quarters · filed 2015-11-12 | $21.39M 10-Q · filed 2015-11-12 | $25.87M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | $5.75M 10-Q · filed 2015-08-12 | $11.29M 10-Q · filed 2015-08-12 | $15.77M derived: sum of 3 quarters · filed 2016-03-15 | $19.89M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $5.54M 10-Q · filed 2015-05-14 | $10.02M derived: sum of 2 quarters · filed 2016-03-15 | $14.14M derived: sum of 3 quarters · filed 2016-03-15 | $18.66M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $4.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $8.60M derived: sum of 2 quarters · filed 2016-03-15 | $13.12M derived: sum of 3 quarters · filed 2016-03-15 | $16.66M 10-K · filed 2016-03-15 |
| 2013-09-30 | $4.12M 10-Q · filed 2014-11-13 | $8.64M derived: sum of 2 quarters · filed 2014-11-13 | $12.18M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $4.52M 10-Q · filed 2014-09-08 | $8.06M 10-Q · filed 2014-09-08 | ||
| 2012-12-31 | $13.84M 10-K · filed 2015-03-31 |